Sartorius Aktiengesellschaft (SARTF)

Market Cap	16.41B
Revenue (ttm)	3.72B
Net Income (ttm)	103.33M
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	158.80
Forward PE	n/a
Dividend	0.79 (0.48%)
Ex-Dividend Date	Mar 28, 2025

Volume	3
Average Volume	31
Open	218.30
Previous Close	207.52
Day's Range	218.30 - 218.30
52-Week Range	165.00 - 290.00
Beta	1.33
RSI	59.50
Earnings Date	Apr 16, 2025

About SARTF

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cy...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1870
• Employees: 13,528
• Stock Exchange: OTCMKTS
• Ticker Symbol: SARTF

Financial Performance

In 2024, SARTF's revenue was 3.38 billion, a decrease of -0.44% compared to the previous year's 3.40 billion. Earnings were 84.00 million, a decrease of -59.14%.

Financial numbers in EUR